Incyte (NASDAQ:INCY) reported Q2 EPS of $1.01, $0.45 better than the analyst estimate of $0.56. Revenue for the quarter came in at $911 million versus the consensus estimate of $814.9 million.
Incyte (NASDAQ:INCY) reported Q2 EPS of $1.01, $0.45 better than the analyst estimate of $0.56. Revenue for the quarter came in at $911 million versus the consensus estimate of $814.9 million.